Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 125 participants.

Also called NCT05988450

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 125 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05988450
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05988450. Allocation not applicable; no masking; primary purpose treatment. Start 2022-03-07 (actual); primary completion 2023-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness Study of SQ-Kyrin TMVr System for Functional Mitral Regurgitation
Condition
Functional Mitral Regurgitation
Intervention (Device)
SQ-Kyrin Transcatheter Mitral Valve Repair System
Lead sponsor
Shanghai Shenqi Medical Technology Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct05988450
Content hash
5d8c157b6df2745859cacf089a9aa1611e3aa47c2e0b014294f67925fca35795